Malignant histiocytosis a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies

Cancer

Volumn 66, Issue 3, 1990, Pages 530-536

  Wilson, Morgan S ^a   Weiss, Lawrence M ^a,b   Gatter, Kevin C ^c   Mason, David Y ^c   Dorfman, Ronald F ^a   Warnke, Roger A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Oxford ^*

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALIGNANT HISTIOCYTOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, MALIGNANT; HUMAN; IMMUNOLOGIC TECHNIQUES; LYMPHOMA; MALE; MIDDLE AGE; PHENOTYPE; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0025325803     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19900801)66:3<530::AID-CNCR2820660321>3.0.CO;2-6     Document Type: Article

References (36)

1. Histiocytic medullary reticulosis
2. Hematophagic histiocytosis: A report of 23 new patients and a review of the literature
3. Frequent immunoglobulin and T‐cell receptor gene rearrangements in “histiocytic neoplasms.”
4. A clinicopathologically distinctive primary histiocytic neoplasm: Demonstration of its histiocytic derivation by immunophenotypic and molecular genetic analysis
5. Sinusoidal hematolymphoid malignancy (malignant histiocytosis) presenting as atypical sinusoidal proliferation: A study of nine cases
6. Sinusoidal large cell (“histiocytic”) lymphoma
7. Co‐expression of epithelial membrane antigen (EMA), Ki‐1 and interleukin‐2 receptor by anaplastic large cell lymphomas: Diagnostic value in so‐called malignant histiocytosis
8. Malignant histiocytosis (true histiocytic lymphoma): Clinicopathological study of 25 cases
9. Malignant histiocytosis (histiocytic medullary reticulosis): I. Clinicopathologic study of 29 Cases
10. Utilization of monoclonal antibody L26 in the identification and confirmation of B‐cell lymphomas: A sensitive and specific marker applicable to formalin and B5‐fixed, paraffin‐embedded tissues
11. Monoclonal antibody (UCHL1) that recognizes normal and neoplastic T‐cells in routinely fixed tissues
12. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma with emphasis on T‐cell lymphomas
13. Immunophenotyping of non‐Hodgkin's lymphomas using a panel of antibodies on paraffin‐embedded tissues
14. Detection of T cells in paraffin embedded tissue using antibodies against a peptide sequence from the CD3 antigen
15. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies
16. KP1 (CD68): A new monoclonal antibody detecting a monocyte/macrophage associated antigen in routinely processed tissue sections
17. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti‐alkaline phosphatase (APAAP complexes)
18. Erythrophagocytic T gamma lymphoma: A clinicopathologic entity resembling malignant histiocytosis
19. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis
20. Immunophenotype analysis of malignant histiocytosis of the intestine
21. Malignant histiocytosis of the intestine: A T‐cell lymphoma
22. Detailed phenotypic analysis of B‐cell lymphoma using a panel of antibodies reactive in routinely fixed wax‐embedded tissue
23. Immunophenotypic criteria for the diagnosis of non‐Hodgkin's lymphoma
24. Large cell hematolymphoid neoplasms of uncertain lineage
25. Fulminant course of infectious mononucleosis with virus‐associated hemophagocytic syndrome
26. Immunophenotypic diagnosis of non‐Hodgkin's lymphoma in paraffin sections: Co‐expression of L60 (leu 22) and L26 antigens correlates with malignant histology
27. Malignant histiocytosis with rearrangement of the heavy chain gene and evidence of monocytemacrophage lineage
28. Histiocytic malignancies: Morphologic, immunologic, and enzymatic heterogeneity
29. Diagnostic significance of histiocyte‐related markers in malignant histiocytosis and true histiocytic lymphoma
30. Comparative immunohistochemical investigation of markers for malignant histiocytes
31. The expression of the Hodgkin's disease associated antigen Ki‐1 in reactive and neoplastic lymphoid tissue: Evidence that Reed‐Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
32. Childhood Ki‐1 lymphoma presenting with skin lesions and peripheral lymphadenopathy
33. Ki‐1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma
34. Anaplastic large cell Ki‐1 lymphoma: Delineation of two morphological types
35. CD30‐positive large cell lymphomas (“Ki‐1 lymphoma”) are associated with a chromosomal translocation involving 5q35